Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Capital Expenditures (2016 - 2025)

INVO Fertility (IVF) has disclosed Capital Expenditures for 10 consecutive years, with $8062.0 as the latest value for Q3 2025.

  • Quarterly Capital Expenditures changed N/A to $8062.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $110463.0 through Sep 2025, down 38.57% year-over-year, with the annual reading at $183703.0 for FY2024, 58.69% down from the prior year.
  • Capital Expenditures for Q3 2025 was $8062.0 at INVO Fertility, down from $8877.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $108217.0 in Q3 2023, with the low at -$328537.0 in Q4 2021.
  • Average Capital Expenditures over 5 years is $6212.1, with a median of $8877.0 recorded in 2025.
  • The sharpest move saw Capital Expenditures tumbled 1519.37% in 2021, then surged 55655.56% in 2023.
  • Over 5 years, Capital Expenditures stood at -$328537.0 in 2021, then soared by 99.96% to -$135.0 in 2022, then soared by 55655.56% to $75000.0 in 2023, then rose by 5.17% to $78874.0 in 2024, then crashed by 89.78% to $8062.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $8062.0, $8877.0, and $14650.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.